David Hollander - 04 Feb 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role
Chief R&D Officer
Signature
/s/ John LaRocca, Attorney-in-Fact for David Hollander
Issuer symbol
N/A
Transactions as of
04 Feb 2022
Net transactions value
-$6,535
Form type
4
Filing time
08 Feb 2022, 19:40:33 UTC
Previous filing
03 Feb 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Tax liability $6,535 -927 -2.9% $7.05 30,749 04 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.